contract_awardAwarded Monday, July 20, 2026Analyzed

HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $322M Department of Health and Human Services Grant

Neutral

Summary

The California Department of Health Care Services received a $322M grant from SAMHSA for opioid and stimulant response (SOR 4). As the recipient is a state government entity, no publicly traded companies are directly awarded, and no tickers are mapped.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.No publicly traded company is directly awarded this contract.
  • 2.The $322M grant supports California's opioid and stimulant response but lacks identifiable corporate beneficiaries.
  • 3.Investors should monitor future subcontracting opportunities or named vendors for potential stock impacts.

Market Implications

The contract has no direct market implications for publicly traded stocks. The healthcare sector may see indirect tailwinds from increased federal focus on substance use disorder treatment, but without specific corporate recipients, no actionable trades emerge.

Full Analysis

This contract is a $322M project grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) to the California Department of Health Care Services (DHCS) for the State Opioid Response (SOR) IV program. The grant aims to expand evidence-based treatment for opioid and stimulant use disorders, focusing on underserved populations and areas with high overdose death rates. Since the recipient is a state government agency, there is no direct publicly traded company beneficiary. The contract does not flow through a public parent or subsidiary, and no specific subcontractors are identified in the award description. The healthcare sector broadly benefits from increased federal spending on substance use disorder treatment, but no individual public company can be reliably linked to this award. Related legislation, such as HR6580 (VA National Formulary Act) and S5006 (Work Without Worry Act), are neutral and low-impact, providing no direct funding mechanism for this grant. Historically, similar SAMHSA grants to state agencies do not create identifiable stock catalysts for public companies unless specific subcontractors are named. Without named subcontractors or supply chain partners, this contract does not generate actionable investment signals.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Contract Details

Recipient

HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF

Award Amount

$322,294,432

Awarding Agency

Department of Health and Human Services

Sub-Agency

Substance Abuse and Mental Health Services Administration

Contract Type

PROJECT GRANT (B)

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →